Clinical trials sponsored by University of Erlangen-Nürnberg Medical School
10
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 2 1Phase 4 1Not applicable 8
Conditions studied
Recruiting trials led by University of Erlangen-Nürnberg Medical School
- Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
- Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers
- Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis
- Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
- Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
- Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
- More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)
- OCTA in Cardiovascular Disease and Healthy Controls
- Predicting Cancer Risk With Digital and Molecular Markers
- Smart and Fit for Kidney Transplantation
Common questions
How many trials is University of Erlangen-Nürnberg Medical School recruiting for?
University of Erlangen-Nürnberg Medical School is the lead sponsor of 10 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.